Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Epidiolex ANDA.

<< Previous

Bullboard Posts

Next >>

Comment by alleyesonmeon Dec 22, 2024 9:55pm

52 Views

Post# 36374497

RE:Epidiolex ANDA.

Interestingly, typo, Abbreviated New Drug Application (ANDA) submitted to the FDA in September 2023 ...should read 2022..furthermore..Jazz did not file suit until January 3rd 2023. ANDA submission includes notification to the patent holder (Jazz)..suit Wasn't filed within 45 days, therefore no 30 month stay issued by the FDA for our partner.

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season